Caption Management, LLC Galapagos Nv Call Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$34.17 - $42.98 $512,550 - $644,700	15,000 Added 50.0%	45,000 $1.55 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $44.52 $2.39 Million - $2.84 Million	-63,800 Reduced 68.02%	30,000 $1.22 Million
Q4 2022 Feb 14, 2023	BUY	$37.44 - $46.51 $3.51 Million - $4.36 Million	93,800 New	93,800 $4.16 Million
Q1 2022 May 13, 2022	SELL	$51.32 - $68.5 $1.54 Million - $2.06 Million	-30,000 Reduced 22.22%	105,000 $6.51 Million
Q4 2021 Feb 11, 2022	BUY	$47.03 - $57.12 $2.82 Million - $3.43 Million	60,000 Added 80.0%	135,000 $7.44 Million
Q3 2021 Nov 12, 2021	BUY	$52.17 - $70.2 $3.91 Million - $5.27 Million	75,000 New	75,000 $3.95 Million
Q1 2020 May 15, 2020	SELL	$143.0 - $274.03 $2.86 Million - $5.48 Million	-20,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$146.12 - $215.82 $2.92 Million - $4.32 Million	20,000 New	20,000 $4.14 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.